Thus, the effects of dietary ω-3 and ω-6 FFAs (or their ratios) on glucose homeostasis and metabolic syndrome may depend on their substrate effects to produce HODEs vs. HEPEs, rather than their systemic effects to alter other cellular functions (e.g., insulin secretion). This evidence concerns the gene INS and metabolic syndrome.